Key result
A high pressure liquid chromatography assay for 18-β-glycyrrhetinic acid in plasma demonstrated excellent linearity, recovery >95%, and within-run precision CV of 3.4-5.6%.
The developed HPLC assay provides a specific, sensitive, and reproducible method for quantifying 18-β-glycyrrhetinic acid in plasma for clinical pharmacology studies.
Enables plasma quantification for pharmacology studies; leaves open broader clinical validation and adoption.
This report presents a useful high pressure chromatography assay for determination of the proposed chemopreventive agent 18-β-glycerrhetinic acid (GA) in murine and human plasma. Drug was released from plasma proteins through precipitation with a mixture of sodium bisulfate and sodium chloride after which it was extracted with acetonitrile. Standard calibration curves of GA covered the concentration range of 2.5 to 120 μg/ml. The lower limit of detection was 0.5 μg/ml. No endogenous plasma constituents from plasma were found to interfere with the determination of GA. Recover of GA from plasma was greater than 95% over a concentration range of 20 to 100 μg/ml. Linearity of the assay was excellent; within-run precision showed a C.V. of 4.2% at 25 μg/ml, 5.6% at 20 μg/ml and 3.4% at 120 μg/ml. Between-run assay precision and accuracy was also considered to be excellent. The specificity, sensitivity and reproducibility of the procedure are adequate for proposed clinical pharmacology studies of this agent.
No takes yet. Share an insight, caveat, or question.
Newman et al. (1990) studied this question. High pressure liquid chromatography assay for 18-β-glycyrrhetinic acid was evaluated on Assay linearity, precision, and recovery. A high pressure liquid chromatography assay for 18-β-glycyrrhetinic acid in plasma demonstrated excellent linearity, recovery >95%, and within-run precision CV of 3.4-5.6%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: